| Serial Number | 97566246 |
| Word Mark | SIMPLICUE |
| Filing Date | Friday, August 26, 2022 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Monday, October 21, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, July 25, 2023 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for human use for the treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies for medical use; Prefilled syringes containing pharmaceutical preparations for the treatment of cardiovascular diseases, central nervous system diseases and disorders, stroke, cancer, inflammation and inflammatory diseases, auto-immune diseases, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, September 14, 2022 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Tuesday, August 30, 2022 | NEW APPLICATION ENTERED |
| Wednesday, September 14, 2022 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, March 8, 2023 | ASSIGNED TO EXAMINER |
| Thursday, March 16, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, March 16, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, March 16, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, June 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, June 14, 2023 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, June 14, 2023 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 20, 2023 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, July 5, 2023 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, July 25, 2023 | PUBLISHED FOR OPPOSITION |
| Tuesday, July 25, 2023 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Tuesday, September 19, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, February 7, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, February 7, 2024 | SOU EXTENSION 1 FILED |
| Wednesday, February 7, 2024 | SOU EXTENSION 1 GRANTED |
| Friday, February 9, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, October 21, 2024 | ABANDONMENT - NO USE STATEMENT FILED |
| Monday, October 21, 2024 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |